Miguel Ángel
Ortega Núñez
Profesor/a Titular Universidad
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (10)
2024
-
Connecting epigenetics and inflammation in vascular senescence: state of the art, biomarkers and senotherapeutics
Frontiers in Genetics, Vol. 15
-
Harnessing the Anti-Inflammatory Properties of Polyphenols in the Treatment of Inflammatory Bowel Disease
International Journal of Biological Sciences, Vol. 20, Núm. 14, pp. 5608-5672
2022
-
Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn’s Disease Severity
Biomedicines, Vol. 10, Núm. 3
-
Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies
Current Oncology, Vol. 29, Núm. 4, pp. 2442-2453
-
Oxidative Stress Markers Are Associated with a Poor Prognosis in Patients with Pancreatic Cancer
Antioxidants, Vol. 11, Núm. 4
-
Prognostic role of IRS-4 in the survival of patients with pancreatic cancer
Histology and histopathology, Vol. 37, Núm. 5, pp. 449-459
2021
-
Areas of interest and attitudes toward antiobesity drugs: Thematic and quantitative analysis using twitter
Journal of Medical Internet Research, Vol. 23, Núm. 10
-
Areas of interest and attitudes towards the pharmacological treatment of attention deficit hyperactivity disorder: Thematic and quantitative analysis using twitter
Journal of Clinical Medicine, Vol. 10, Núm. 12
-
Expansion of CD4 T lymphocytes expressing interleukin 17 and tumor necrosis factor in patients with major depressive disorder
Journal of Personalized Medicine, Vol. 11, Núm. 3
-
Tissue remodelling and increased DNA damage in patients with incompetent valves in chronic venous insufficiency
Journal of Cellular and Molecular Medicine, Vol. 25, Núm. 16, pp. 7878-7889